Keiji Anzai

Keiji Anzai currently serves as the Head of Quality Assurance at Clinigen, a position held since May 2025, after a tenure as Head of Quality for Jazz Pharmaceuticals in Japan from March 2024 to April 2025. Prior to that, Keiji held significant roles at Kyowa Kirin Co., Ltd. as the Head of Quality Unit from June 2020 to February 2024, and at Rakuten Medical as Quality Officer and General Manager of CMC Development from April 2019 to May 2020. Extensive experience at Astellas Pharma spanned from April 2005 to March 2019, where Keiji advanced through various senior roles in global quality assurance, culminating as Senior Director. Early career experience includes positions at Yamanouchi Pharmaceuticals Co., Ltd. from April 1991 to March 2005, focusing on biotechnology research.